Exelixis
EXEL
#1580
Rank
S$14.52 B
Marketcap
$51.88
Share price
-0.36%
Change (1 day)
71.22%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company